IBIO, INC.
At iBio, we’re pioneering the next generation of biopharmaceuticals using the fastpharming System, our proprietary plant-based recombinant protein manufacturing platform. The speed, safety and scalability inherent in the FastPharming Technology makes it ideal for rapidly advancing promising candidates from concept to clinic, while also enabling “greener” manufacturing. We seek to change the paradigm of drug development by reducing the time, costs, and scale-up issues associated with traditional mammalian cell culture production – thus making plant-based manufacturing the preferred choice for high quality biopharmaceutical development.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About Us
Plus, our?novel Glycaneering Development Services? provide greater control over the glycosylation of complex biopharmaceuticals. Glycaneering can deliver molecules with greater Antibody-Dependent Cellular Cytotoxicity [ADCC], facilitating the creation of more potent anti-cancer therapeutics. We’ve demonstrated the quality and potency of Glycaneered molecules for our clients, not to mention strong data we’ve generated on plant-made rituximab. We’ve also used Glycaneering to afucosylate our novel anti-CD25 mAb as we convert it from CHO cell production to FastPharming.
We have two facilities; our San Diego, CA, site houses early-stage drug discovery and process development, and our Bryan/College Station, TX, facilty supports bioanalysis, protein characterization, and bioprocess services.
Our experienced team of scientists and engineers helps our clients leverage all of FastPharming’s advantages over mammalian cell culture. We’re experts in plant-based recombinant protein expression and purification process development and are happy to help drug developers avoid expensive media development, risks associated with animal-origin raw materials, master cell bank creation, and other issues associated with mammalian cell culture processes.